WELCOME TO OUR PARKINSON'S PLACE!

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

TRANSLATE

Wednesday, October 1, 2014

What’s In a Number? PDF Parkinson’s Prevalence Project



The recent ice bucket challenge that has raised awareness and funds for ALS has been a huge success. What may have been overshadowed by this success is the reporting of the first solid estimate of how many people in the United States live with ALS – 12,187. It may seem like a small number but it helps many – from families to policy makers – understand what we are up against in solving that disease.
While the estimates of people living with Parkinson’s disease are much larger than for those with ALS, the fact of the matter is that our community does not exactly know the real number.
The numbers range from a low of 430,000 to as many as one and a half million. The low number is based on oft cited research study conducted in the late 1970’s in a sparsely populated county in rural Mississippi. While the study was well done, it might not be a good idea to extrapolate those results to the ethnically and geographically diverse United States.
For the record, the Parkinson’s Disease Foundation believes the number is close to one million. That is an educated guess supported by recent epidemiology data. However, the point remains that the estimates we have remain quite imperfect.
Because knowledge is power and because a fact so basic as how many people have PD remains unanswered, PDF is stepping in to help. We are determined to provide an answer that we all can use with confidence.
With the PDF Parkinson’s Prevalence Project, we are working with a group of noted experts in PD epidemiology to see if we can improve our estimate. The group has been meeting virtually for many months, and will come together for its first major in-person meeting shortly. At this meeting, we plan to work out details on how to improve our estimates of PD prevalence.
We have many months of hard work still ahead but this represents an important step in knowing how many are affected by this terrible disease.

Improved understanding of brain stimulation may improve treatment for neurological and psychiatric disorders

 Oct. 1, 2014
Over the past several decades, brain stimulation has become an increasingly important treatment option for a number of psychiatric and neurological conditions.
Divided into two broad approaches, invasive and noninvasive, brain stimulation works by targeting specific sites to adjust brain activity. The most widely known invasive technique, deep brain stimulation (DBS), requires brain surgery to insert an electrode and is approved by the U.S. Food and Drug Administration (FDA) for the treatment of Parkinson's disease and essential tremor. Noninvasive techniques, including transcranial magnetic stimulation (TMS), can be administered from outside the head and are currently approved for the treatment of depression. Brain stimulation can result in dramatic benefit to patients with these disorders, motivating researchers to test whether it can also help patients with other diseases.
But, in many cases, the ideal sites to administer stimulation have remained ambiguous. Exactly where in the brain is the best spot to stimulate to treat a given patient or a given disease?
Now a new study in the Proceedings of the National Academy of Sciences (PNAS) helps answer this question. Led by investigators at Beth Israel Deaconess Medical Center (BIDMC), the findings suggest that brain networks - the interconnected pathways that link brain circuits to one another - can help guide site selection for brain stimulation therapies.
"Although different types of brain stimulation are currently applied in different locations, we found that the targets used to treat the same disease are nodes in the same connected brain network," says first author Michael D. Fox, MD, PhD, an investigator in the Berenson-Allen Center for Noninvasive Brain Stimulation and in the Parkinson's Disease and Movement Disorders Center at BIDMC.
"This may have implications for how we administer brain stimulation to treat disease. If you want to treat Parkinson's disease or tremor with brain stimulation, you can insert an electrode deep in the brain and get a great effect. However, getting this same benefit with noninvasive stimulation is difficult, as you can't directly stimulate the same site deep in the brain from outside the head," explains Fox, an Assistant Professor of Neurology at Harvard Medical School (HMS). "But, by looking at the brain's own network connectivity, we can identify sites on the surface of the brain that connect with this deep site, and stimulate those sites noninvasively."
Brain networks consist of interconnected pathways linking brain circuits or loops, similar to a college campus in which paved sidewalks connect a wide variety of buildings.
In this paper, Fox led a team that first conducted a large-scale literature search to identify all neurological and psychiatric diseases where improvement had been seen with both invasive and noninvasive brain stimulation. Their analysis revealed 14 conditions: addiction, Alzheimer's disease, anorexia, depression, dystonia, epilepsy, essential tremor, gait dysfunction, Huntington's disease, minimally conscious state, obsessive compulsive disorder, pain, Parkinson disease and Tourette syndrome. They next listed the stimulation sites, either deep in the brain or on the surface of the brain, thought to be effective for the treatment of each of the 14 diseases.
"We wanted to test the hypothesis that these various stimulation sites are actually different spots within the same brain network," explains Fox. "To examine the connectivity from any one site to other brain regions, we used a data base of functional MRI images and a technique that enables you to see correlations in spontaneous brain activity." From these correlations, the investigators were able to create a map of connections from deep brain stimulation sites to the surface of the brain. When they compared this map to sites on the brain surface that work for noninvasive brain stimulation, the two matched.
"These results suggest that brain networks might be used to help us better understand why brain stimulation works and to improve therapy by identifying the best place to stimulate the brain for each individual patient and given disease," says senior author Alvaro Pascual-Leone, MD, PhD, the Director of the Berenson-Allen Center for Noninvasive Brain Stimulation at BIDMC and Professor of Neurology at HMS. "This study illustrates the potential of gaining fundamental insights into brain function while helping patients with debilitating diseases, and provides us with a powerful way of selecting targets based on their connectivity to other regions that can be widely applied to help guide brain stimulation therapy across multiple neurological and psychiatric disorders."
"As we're trying different types of brain stimulation for different diseases, the question comes up, 'How does one relate to the other'?" notes Fox. "In other words, can we use the success in one to help design a trial or inform how we apply a new type of brain stimulation? Our new findings suggest that resting-state functional connectivity may be useful for translating therapy between treatment modalities, optimizing treatment and identifying new stimulation targets."


http://www.medicalnewstoday.com/releases/283202.php

**Cycling, Dancing in PD in Those Who Can’t Walk: Is it Possible?



You can find out more about NPF's National Medical Director, Dr. Michael S. Okun, by also visiting the NPF Center of Excellence, University of Florida Center for Movement Disorders & Neurorestoration.

This month a report appeared in the New England Journal of Medicine by Snijders and Bloem about a patient they encountered in their National Parkinson Foundation Center of Excellence Clinic. The report was accompanied by a dramatic video revealing a late stage Parkinson’s disease patient with severe ambulation difficulties and freezing of gait. The patient had Parkinson’s disease for many years, but his report of being able to ride a bicycle for six or more miles each day struck Dr. Bloem as “very interesting.”

One thing I have personally learned over many years of caring for persons with Parkinson’s disease is that when they tell you something, even if it sounds improbable, it is likely true. Bloem and colleagues did the right thing by following up this special case, and by documenting its occurrence by direct observation. Their report follows in the wake of another observation by Dr. Jay Alberts who demonstrated that tandem biking and forced exercise may be beneficial in Parkinson’s disease. Albert’s observation was made while tandem biking with a Parkinson’s disease patient in the back seat—all the way across the state of Iowa. As a trainee I witnessed a Parkinsonian woman who could not walk, but could dance for hours. How many more of these cases are out there? Can these observations be extended to help others? We hope the answer is yes.
The real question in this case is why does cycling improve symptoms? Why could Bloem’s patient ride a bicycle, but not walk? The answer remains a mystery, but many experts believe the answer may lie deep in the brain within a group of complex communicating structures (e.g. the basal ganglia). This network of structures aid in facilitating motor, mood and cognitive functions. How the basal ganglia works remains one of humankind’s greatest mysteries. We believe that these systems act as advanced data processors modulating complex brain functions by filtering and sorting information. Perhaps it was the basal ganglia itself that facilitated this man’s ability to ride the bike. Alternatively, the basal ganglia may have been bypassed by other brain systems in order to facilitate his complex riding movement. Basal ganglia diseases (e.g. Parkinson’s or other movement disorders) are known to be worsened by stress and anxiety (e.g. sleep deprivation or marital issues), but also are known to be improved by mood, exercise, visual/other cues, as well as many non-pharmacological/non-surgical modalities (e.g. Tai Chi). We need to learn more about how the basal ganglia work.
Dr. Bloem in a recent interview with the NY Times noted that he “was not advocating that Parkinson’s patients hop on bikes and go out on busy roads. They need help in mounting a bike and can get into trouble if they have to stop at traffic lights. They need to ride in safe areas.” He recommended that patients ride tricycles, or use stationary bikes or trainers — devices that turn road bikes into stationary ones. He also intimated that in select patients “bicycling offers an opportunity to be symptom-free, and to get some real cardiovascular exercise even when their disease is so far advanced that they cannot walk.” The Snijders/Bloem observation remains interesting, but we also want to caution all patients with PD not to run out and do it. Sudden offs, balance problems and many other complex issues could lead to crashes and severe injury. It is best to get the advice of a doctor and physical therapist, and if you choose to ride into the sunset on your bike, do it under careful supervision. Finally, in answer to the title of this article, “Is It Possible?” the answer is simple—almost anything is plausible and even possible in a Parkinson’s disease patient. This is the main reason why we as a Parkinson’s disease community are filled with hope and expectation about the future.

Read the full New York Times article here: "Cycling Provides a Break for Some with Parkinson's."
Selected References:
Snijders AH, Bloem BR. Cycling for freezing of gait. N Engl J Med. 2010 Apr 1;362(13):e46. PubMed PMID: 20357278.

Ridgel AL, Vitek JL, Alberts JL. Forced, not voluntary, exercise improves motor function in Parkinson's disease patients. Neurorehabil Neural Repair. 2009 Jul-Aug;23(6):600-8. Epub 2009 Jan 8. PubMed PMID: 19131578.

HORMONES CAN INCREASE THE RISK OF PARKINSON'S DISEASE Movement Disorders


Estrogen

 [2014] Sep 25 [Epub ahead of print] (J.I.Lundin, T.G.Ton, A.Z.
LaCroix, W.T.Longstreth, G.M.Franklin, P.D.Swanson, T.Smith-Weller, B.A.Racette, H.
Checkoway) Complete abstract : http://www.ncbi.nlm.nih.gov/pubmed/25255692


Certain types of commonly used oral contraceptives have been found to greatly increase the risk of developing Parkinson's Disease. Oral contraceptives, which includes estrogen and progestin, are a class of drugs widely prescribed to women. For more information go to :

http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601050.html

Oral contraceptive use by people with Parkinson's Disease were classified as conjugated estrogens, esterified estrogens, orprogestin. Ever having used a hormone therapy formulation demonstrated a suggested elevated risk with esterified estrogen use that was three times the normal. However, there was no
increase in the risk of developing Parkinson's Disease in those
people who had taken conjugated estrogen.

Restricting this analysis to prescriptions that included progestin greatly increased the risk associated with esterified estrogen use, making Parkinson's Disease SEVEN times more likely. Progestin also moderately increased the risk of developing Parkinson's Disease in those people who taken conjugated estrogen.

The findings from this study suggest a great increase in Parkinson's Disease risk associated with the use of esterified estrogen combined with progestin, but no risk is associated with conjugated estrogen on its own.

http://www.viartis.net/parkinsons.disease/news/141001.pdf
mail@viartis.net

©2014 Viartis

Tuesday, September 30, 2014

How physical exercise protects the brain from stress-induced depression


In a study in the journal Cell, Jorge Ruas and Maria Lindskog show how physical exercise protects the brain from stress-induced depression in mice.
Credit: Ulf Sirborn

Physical exercise has many beneficial effects on human health, including the protection from stress-induced depression. However, until now the mechanisms that mediate this protective effect have been unknown. In a new study in mice, researchers at Karolinska Institutet in Sweden show that exercise training induces changes in skeletal muscle that can purge the blood of a substance that accumulates during stress, and is harmful to the brain. The study is being published in the journal Cell.
"In neurobiological terms, we actually still don't know what depression is. Our study represents another piece in the puzzle, since we provide an explanation for the protective biochemical changes induced by physical exercise that prevent the brain from being damaged during stress," says Mia Lindskog, researcher at the Department of Neuroscience at Karolinska Institutet.
It was known that the protein PGC-1a1 (pronounced PGC-1alpha1) increases in skeletal muscle with exercise, and mediates the beneficial muscle conditioning in connection with physical activity. In this study researchers used a genetically modified mouse with high levels of PGC-1a1 in skeletal muscle that shows many characteristics of well-trained muscles (even without exercising).
These mice, and normal control mice, were exposed to a stressful environment, such as loud noises, flashing lights and reversed circadian rhythm at irregular intervals. After five weeks of mild stress, normal mice had developed depressive behaviour, whereas the genetically modified mice (with well-trained muscle characteristics) had no depressive symptoms.
"Our initial research hypothesis was that trained muscle would produce a substance with beneficial effects on the brain. We actually found the opposite: well-trained muscle produces an enzyme that purges the body of harmful substances. So in this context the muscle's function is reminiscent of that of the kidney or the liver," says Jorge Ruas, principal investigator at the Department of Physiology and Pharmacology, Karolinska Institutet.
The researchers discovered that mice with higher levels of PGC-1a1 in muscle also had higher levels of enzymes called KAT. KATs convert a substance formed during stress (kynurenine) into kynurenic acid, a substance that is not able to pass from the blood to the brain. The exact function of kynurenine is not known, but high levels of kynurenine can be measured in patients with mental illness. In this study, the researchers demonstrated that when normal mice were given kynurenine, they displayed depressive behaviour, while mice with increased levels of PGC-1a1 in muscle were not affected. In fact, these animals never show elevated kynurenine levels in their blood since the KAT enzymes in their well-trained muscles quickly convert it to kynurenic acid, resulting in a protective mechanism.
"It's possible that this work opens up a new pharmacological principle in the treatment of depression, where attempts could be made to influence skeletal muscle function instead of targeting the brain directly. Skeletal muscle appears to have a detoxification effect that, when activated, can protect the brain from insults and related mental illness," says Jorge Ruas.
Depression is a common psychiatric disorder worldwide. The World Health Organization (WHO) estimates that more than 350 million people are affected.
end text


Story Source:
The above story is based on materials provided by Karolinska Institutet. Note: Materials may be edited for content and length.
end story_source

Journal Reference:

Leandro Z. Agudelo, Teresa Femenía, Funda Orhan, Margareta Porsmyr-Palmertz, Michel Goiny, Vicente Martinez-Redondo, Jorge C. Correia, Manizheh Izadi, Maria Bhat, Ina Schuppe-Koistinen, Amanda Pettersson, Duarte M. S. Ferreira, Anna Krook, Romain Barres, Juleen R. Zierath, Sophie Erhardt, Maria Lindskog, and Jorge L. Ruas. Skeletal Muscle PGC-1a1 Modulates Kynurenine Metabolism and Mediates Resilience to Stress-Induced Depression. Cell, September 2014